Recent studies reveal that approximately 8% of primary neuroblastomas have a mutation in the anaplastic lymphoma kinase (ALK) gene [4–7], which encodes a receptor tyrosine kinase. The gene discussed is NTRK1; the disease is neuroblastoma.